Press release
Cancer Diagnostics Market to Reach USD 156.97 Billion by 2029, Driven by Advancements in Biomarkers and Imaging Technologies
Cancer Daignostics Market Size
The global cancer diagnostics market, valued at USD 106.24 billion in 2024, is projected to grow to USD 156.97 billion by 2029, registering a compound annual growth rate (CAGR) of 8.12%. The market's growth is fueled by the rising prevalence of cancer, advancements in diagnostic technologies such as biomarkers and point-of-care diagnostics, and increasing accessibility to early screening tools. Despite challenges posed by high diagnostic costs and regulatory frameworks, the market is poised for robust growth, supported by innovations and global awareness initiatives.
Report Overview: https://www.mordorintelligence.com/industry-reports/cancer-diagnostic-market
Key Trends
1. Rising Global Cancer Prevalence
The escalating number of cancer cases worldwide is a significant driver for the diagnostics market:
According to Globocan, over 30 million people are expected to live with cancer by 2040, emphasizing the need for early and accurate diagnosis.
The geriatric population, a high-risk demographic, is increasingly utilizing cancer screening tests, boosting demand for diagnostic procedures.
2. Advancements in Diagnostic Imaging
Imaging technologies continue to dominate cancer diagnostics due to their reliability and continuous innovation:
Technologies like CT scans, MRIs, and mammograms remain the cornerstone of cancer detection.
Recent innovations, such as the NearWave Imager for breast cancer detection developed in 2022, highlight the ongoing advancements in imaging technologies.
3. Technological Innovations in Biomarkers and Point-of-Care Diagnostics
Biomarkers are revolutionizing cancer diagnostics by enabling precision medicine:
The use of liquid biopsies and genetic markers facilitates early detection and monitoring, offering non-invasive diagnostic solutions.
Point-of-care technologies are becoming more accessible, expanding diagnostic capabilities even in low-resource settings.
4. Growing Awareness and Screening Initiatives
Awareness campaigns and screening programs are driving market growth:
Initiatives like the American College of Radiology's Contrast-Enhanced Mammography Imaging Screening Trial aim to improve breast cancer detection rates and reduce false positives.
Market Segmentation
The cancer diagnostics market is segmented by Diagnostic Type, Application, and Geography:
By Diagnostic Type:
Diagnostic Imaging Tests: Includes CT scans, MRIs, mammograms, and X-rays.
Biopsy and Cytology Tests: Gold-standard methods for confirming cancer diagnosis.
Tumor Biomarkers: Enabling precision medicine and non-invasive diagnosis.
By Application:
Breast Cancer: Most widely diagnosed with advancements in mammography and imaging.
Lung Cancer: High demand for early detection technologies.
Cervical Cancer: Increasing adoption of HPV tests and Pap smears.
Other Cancers: Includes liver, pancreatic, and ovarian cancers.
By Geography:
North America: Largest market due to advanced healthcare infrastructure and high awareness.
Asia-Pacific: Fastest-growing region, driven by a rising cancer burden and healthcare investments.
Europe: Strong focus on innovation and healthcare policies supporting diagnostics.
Middle East & Africa, South America: Emerging markets with increasing awareness and diagnostic access.
Get a Customized Report Tailored to Your Requirements - https://www.mordorintelligence.com/market-analysis/diagnostic-devices
Key Players
The cancer diagnostics market features key players leveraging innovation and partnerships to maintain leadership. Major companies include Siemens Healthineers, GE Healthcare, Roche Diagnostics, Thermo Fisher Scientific, and Hologic, Inc.
Siemens Healthineers: Known for its advanced imaging solutions, including the Naeotom Alpha launched in 2021 for enhanced diagnostics.
GE Healthcare: Focuses on improving cancer detection through advanced imaging and AI solutions.
Roche Diagnostics: A leader in biomarker development and precision diagnostics.
Thermo Fisher Scientific: Innovates in genetic and liquid biopsy diagnostics.
Hologic, Inc.: Specialized in breast cancer screening technologies like advanced mammography systems.
These companies are actively investing in research and development to offer cutting-edge diagnostic tools and improve cancer care outcomes.
Conclusion
The cancer diagnostics market is set for substantial growth, driven by rising cancer prevalence, advancements in technology, and increased awareness about early detection. As imaging and biomarker technologies continue to evolve, the market is expected to play a critical role in enhancing patient outcomes and reducing cancer mortality rates. With major players focusing on innovation and expanding access to diagnostic tools globally, the cancer diagnostics market is poised to meet the growing demand for early and accurate detection in the years ahead.
Industry Related Reports
Brain Tumor Diagnostics Market: The report highlights trends in the Brain Dead Diagnosis and Treatment Market, which is segmented by Diagnostic Type (Imaging Tests, Lumbar Puncture, Biopsy, Molecular Testing, and Others), Tumor Type (Metastatic, Meningioma, Glioblastoma, Pituitary Adenoma, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more vsit this link: https://www.mordorintelligence.com/industry-reports/brain-tumor-diagnostics-market
Tissue Diagnostics Market: The Report is segmented by Product (Instruments and Reagents & Consumables), Technology (Immunohistochemistry, In-Situ Hybridization, Digital Pathology & Workflow Management, and Other Technologies), Application (Breast Cancer, Prostate Cancer, Gastric Cancer, and Other Cancers), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/global-tissue-diagnostics-market-industry
Thyroid Cancer Diagnostics Market: The Market is segmented by Disease Type (Papillary Carcinoma, Follicular Carcinoma, and Other Disease Types), Diagnostic Technique (Blood Tests, Imaging, Biopsy, and Other Diagnostic Techniques), End User (Hospital Laboratories, Cancer Diagnostic Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
To know more visit this link: https://www.mordorintelligence.com/industry-reports/thyroid-cancer-diagnostics-market
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Diagnostics Market to Reach USD 156.97 Billion by 2029, Driven by Advancements in Biomarkers and Imaging Technologies here
News-ID: 3756103 • Views: …
More Releases from Mordor Intelligence
Medium Voltage Cable Market Growing at 5.40% CAGR, Driven by Grid Expansion and …
Mordor Intelligence has published a new report on the "Medium Voltage Cable Market," offering a comprehensive analysis of trends, growth drivers, and future projections.
Medium Voltage Cable Market Introduction:
The Medium Voltage Cable Market is projected to reach USD 66.78 billion by 2030, growing from USD 51.34 billion in 2025 at a CAGR of 5.40% during the forecast period (2025-2030). This steady growth is fueled by large-scale investments in power infrastructure, the…
Lung Cancer Therapeutics Market to Reach USD 50.34 Billion by 2030; Poised for D …
Mordor Intelligence has published a new report on the "lung cancer therapeutics market" offering a comprehensive analysis of trends, growth drivers, and future projection
Introduction
The lung cancer therapeutics market size is valued at USD 27.89 billion in 2025 and is forecast to reach USD 50.34 billion by 2030, translating into a 12.54% CAGR. Rising lung cancer incidence, broader adoption of precision diagnostics, and accelerating approvals of novel agents are…
Waterproofing Membranes Market Growing at 5.82% CAGR, South America Emerges as F …
The waterproofing membranes market is projected to rise from USD 23.36 billion in 2025 to USD 31 billion by 2030, expanding at a steady CAGR of 5.82% during the forecast period (2025-2030). The market's momentum is driven by surging construction activity, infrastructure modernization, and increasing emphasis on moisture protection and durability across industrial, residential, and commercial structures.
According to Mordor Intelligence, Asia-Pacific continues to hold the largest share of the market,…
Carotenoids Market Size to Reach USD 2.63 Billion by 2030, Driven by Clean-Label …
Introduction to the Carotenoids Market
The carotenoids market, valued at USD 2.09 billion in 2025, is projected to reach USD 2.63 billion by 2030, at a CAGR of 4.64% during the forecast period. Growth is strongly linked to rising consumer awareness around natural ingredients, ingredient transparency, and preventive health benefits. With applications spanning food and beverage, dietary suppIements, pharmaceuticals, cosmetics, and animal feed, carotenoids are emerging as a versatile ingredient…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
